Acacia Pharma Group Stock CINNOBER BOAT

0PNT

GB00BYWF9Y76

OTC Markets Traded

Latest news : Acacia Pharma Group

07-16	Acacia Pharma Group plc Announces the Termination of Debra Marie Hussain as Director, Effective July 13, 2026	CI
25-02-03	Acacia Pharma Group plc Auditor Raises 'Going Concern' Doubt	CI
25-02-03	Acacia Pharma Group plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-07-21	Acacia Pharma Limited Appoints Debra Marie Hussain as Director	CI
22-06-09	Eagle Pharmaceuticals Completes Acacia Pharma Acquisition	MT
22-06-09	Acacia Pharma's Acquisition by Eagle Pharmaceuticals Closes; Shares Delist	MT
22-06-08	Acacia Pharma Group plc(ENXTBR:ACPH) dropped from Next Biotech Index	CI
22-06-07	Acacia Pharma's Acquisition by Eagle Pharmaceuticals Nears Completion	MT
22-06-05	Eagle Pharmaceuticals, Inc. completed the acquisition of Acacia Pharma Group plc from a group of shareholders.	CI
22-04-28	Acacia Pharma Group plc Auditor Raises 'Going Concern' Doubt	CI
22-04-28	Acacia Pharma Group plc Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-03-28	Health Care Up on Revival of Demand for Growth Sectors -- Health Care Roundup	DJ
22-03-28	FTSE 100 Closes Lower Despite Earlier Hopes on Russia, Ukraine Talks	DJ

More news

Analysts' recommendations: Acacia Pharma Group

21-10-01

Analyst recommendations: Acceleron Pharma, General Mills, Southwest Airlines, Home Depot, Wizz Air...

More recommendations

Press Releases: Acacia Pharma Group

22-06-09	Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group plc, Expanding Acute Care Footprint	AQ
22-06-09	Scheme of arrangement becoming effective	GL
22-06-09	Scheme of arrangement becoming effective	AQ
22-06-07	Court Sanction of the Scheme of Arrangement	GL
22-06-07	Court Sanction of the Scheme of Arrangement	AQ

More press releases

News in other languages: Acacia Pharma Group

22-06-07	Bel20 beperkt zijn verliezen bij het slot
22-06-07	Brussel in het rood
22-06-07	Overname Acacia afgerond
22-05-20	Bel20 sluit week hoger af
22-05-20	Brussel omhoog

More news

Managers and Directors: Acacia Pharma Group

Manager	Title	Age	Since
Gabriel Fox CTO	Chief Tech/Sci/R&D Officer	-	2007-12-31
Debra M. Hussain PRN	Corporate Officer/Principal	-	2021-05-18
Anne-Marie Elsley SEC	Corporate Secretary	-	2020-02-28

Director	Title	Age	Since
Scott A. Byrd CHM	Chairman	56	2020-03-01
John Brown BRD	Director/Board Member	71	2018-02-28
Ed Borkowski BRD	Director/Board Member	66	2018-02-28

More insiders

Acacia Pharma Group plc specializes in the research and development of supportive care medicines. The products are intended to support the side effects of anti-cancer treatments (including nausea and vomiting drugs). At the end of 2021, the group had a portfolio of 3 products, including 1 in phase II of clinical development (APD403; treatment of chemically induced nausea and vomiting) and 2 in pre-launch phase: BARHEMSYS (treatment of nausea and postoperative vomiting) and BYFAVO (benzodiazepine sedative for use in invasive medical procedures in adults, such as colonoscopy and bronchoscopy).

Employees

Sector

More about the company